Still a bull sentiment on this stock from the chart technicals standpoint and certainly from a product demand standpoint.
Titan Pharmaceutical Shares Rising After Trump Signs Anti-Opioid Bill -- Market Mover
2:36 pm ET October 24, 2018 (Dow Jones) Print
Shares of South San Francisco-based Titan Pharmaceuticals are rising in Wednesday trading, with the stock gaining 11.46% to 53 1/2 cents at 2:24 p.m. EDT. Volume is very heavy, at 53.1 million shares, well above the 65-day average volume of 4.5 million. The company's lead product is a probuphine implant for the long-term maintenance treatment of opioid dependence. Earlier in the day, President Donald Trump signed an anti-opioid addiction bill which, among other things, allows for the delivery of anti-opioid medicines via injection or implantation. (stephen.nakrosis@wsj.com)
(END) Dow Jones Newswires